Column
You can view the research column published every month by SMC Laboratories.
2024.04.08
【Hot data】 Resmetirom (MGL-3196) evaluation data available in STAMTM model
MASH
Resmetirom
STAM
As you may already know, the United States Food and Drug Administration (FDA) announced the approval of Rezdif…
READ MORE
2024.03.21
What is the best non-clinical liver cancer model with 100% cancer incidence rate and suitable for liver cancer assessment?
If you are considering a drug evaluation study for liver cancer using a mouse model, our STAMTM-HCC/IO+ model …
READ MORE
2024.03.19
[ Breaking News! ] First MASH treatment approved by FDA
On March 14th, industry-altering news was published. Do you know already what we are talking about? The United…
READ MORE
2024.03.15
[Existing compounds] that have advanced to clinical trials will accelerate the launch of your drugs.
If you are planning to launch your therapeutic drug, you should select disease mouse models that have shown ac…
READ MORE
2024.03.15
Pitfalls of [ disease model mice ] that researchers unknowingly fall into.
In order to evaluate your compound, rather than using a general pulmonary fibrosis model that does not match y…
READ MORE
2024.03.15
| A must for IPF researchers! | Suggestions for the best disease model for your research
If you are considering a drug efficacy study using a mouse model of lung fibrosis, you should use a model that…
READ MORE
